Sort
48,018 grants matching “immunotherapy”
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$567,039Anant Madabhushi · Emory University · R01 · FY2022 · CA
Chemokine interaction with CXCR4 and ACKR3: structure and activation mechanisms
$567,004Tracy M Handel · University Of California, San Diego · R01 · FY2016 · GM
MECHANISMS OF MURINE TUMOR ERADICATION BY IMMUNOTHERAPY
$566,963University Of Washington · R37 · FY2005 · CA
Optimizing Syngeneic Mouse Models to Target Mutant p53
$566,963Yong Li · Baylor College Of Medicine · R01 · FY2024 · CA
Characterizing the sources, mechanisms, and translational relevance of microbial TMAO in driving anti-tumor immunity in pancreatic cancer.
$566,752Rahul Suresh Shinde · Wistar Institute · R37 · FY2025 · CA
Stanford Project 2
$566,735Calvin J Kuo · University Of California, San Francisco · U54 · FY2019 · CA
Advancing the Coordinating Center for the Canine Cancer Immunotherapy Network
$566,719Nicola J Mason · University Of Pennsylvania · U24 · FY2022 · CA
Multiscale systems biology modeling to exploit tumor-stromal metabolic crosstalk in colorectal cancer
$566,680Stacey Deleria Finley · University Of Southern California · U01 · FY2020 · CA
Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD
$566,578Jonathan Kipnis · Washington University · R01 · FY2025 · AG
A SIM2s/SEMA7A Switch Drives ER+ Breast Cancer Progression
$566,462Traci Lyons · University Of Colorado Denver · R01 · FY2024 · CA
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
$566,443Gregoire Stephane Lauvau · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Developmental Funds
$566,429Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2021 · CA
Developmental Funds
$566,429Taofeek K Owonikoko · University Of Maryland Baltimore · P30 · FY2024 · CA
Developmental Funds
$566,429Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2022 · CA
Developmental Funds
$566,429Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2023 · CA
Immunobiology of Normal and Neoplastic Lymphocytes
$566,422Warren S Pear · University Of Pennsylvania · T32 · FY2021 · CA
Modulation of ferroptotic cell death by mitochondrial calcium signaling
$566,379Haitao Wen · Ohio State University · R01 · FY2025 · CA
Modulation of ferroptotic cell death by mitochondrial calcium signaling
$566,379Haitao Wen · Ohio State University · R01 · FY2024 · CA
Strategies for Therapeutic Cancer Vaccine Clinical Trials
$566,341Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Strategies for Cancer Vaccine Development: Preclinical Studies
$566,341Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Nanovaccine platforms to combat pancreatic cancer
$566,261Balaji Narasimhan · Iowa State University · U01 · FY2017 · CA
Delineating Functional Immunity via Image-Guided PET
$566,226Nerissa Therese Viola · Wayne State University · R37 · FY2018 · CA
Chemotherapy and the Bladder Cancer Immune Microenvironment
$566,138William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Chemotherapy and the Bladder Cancer Immune Microenvironment
$566,138William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response
$566,131Jeremiah Allen Johnson · Massachusetts Institute Of Technology · R01 · FY2024 · CA